Tool Sprawl Risk Audit — Specialty Pharmacy

Find out how much spreadsheet and SaaS sprawl is costing Specialty Pharmacy — and where a purpose-built internal tool pays off.

Signs of tool sprawl in Specialty Pharmacy

PBM dynamics — formulary placement, network access, contract terms, DIR fees, and rebate flow — shape the realized economics on every script and the operating model has to be defended every contract cycle.
Prior authorization and benefits investigation are the gating workflow on every specialty start; the cycle time and approval rate are commercial and clinical KPIs.
Hub services for biopharma manufacturers (patient assistance, copay support, adherence, REMS) is a high-touch operating model that runs on data, calls, and document workflow.
Specialty-product cold-chain logistics, dispensing accreditation (URAC, ACHC), and limited-distribution-drug (LDD) network access are operating prerequisites with sustained compliance overhead.

Section 1 of 4 · Source of Truth0/8 answered

Source of Truth

Whether your operational data lives in one place or is scattered across tools.

1.Where does your core operational data live?

2.How many tools/spreadsheets hold 'the truth' for one workflow?

Score process clarity, data readiness, team adoption, and guardrails before investing in AI.

Sample output

67/100 → pilot with control, not full rollout

Assess KPI clarity, reporting, tool alignment, ownership, and automation maturity.

Sample output

52/100 → foundation gaps in metrics and handoffs

Assess supplier diversification, cost visibility, pricing competitiveness, and negotiation strength.

Sample output

65/100 → 3-5% cost reduction opportunity

Quantify the annual cost and people-weeks lost to repetitive manual work — and the automation payback.

Compare the multi-year total cost of SaaS subscriptions against a custom build — with a clear build, buy, or hybrid recommendation.

See how much revenue leaks every month from a low conversion rate — and what closing the gap to your target is worth.